Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...

Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using.

Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using. Previously, this phenomenon was attributed to a decline ...

I was like, ‘Is this real?’ because there is nothing like it,” lead author and clinical epidemiologist Ziyad Al-Aly said. “This is an obesity and diabetes drug; this is not an addiction ...

One of the most famous examples is psilocybin, a natural compound found in so‑called “magic mushrooms.” Over the past decade, ...

Originally designed for diabetes and obesity, GLP-1-based drugs may also blunt the brain's reward signals that drive alcohol, tobacco and drug cravings.

A new study reveals how cocaine use alters brain circuits tied to memory and reward, leaving the brain more vulnerable to relapse.

Cocaine addiction isn’t simply a failure of willpower — it’s the result of lasting biological changes in the brain.

FORT LAUDERDALE, FL - March 06, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has published a new educational ...